[
  {
    "ts": null,
    "headline": "Why IQVIA (IQV) Stock Is Trading Up Today",
    "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215. The adjustment from the investment bank suggested a more positive outlook on the stock's potential value. This move occurred while the company maintained an average rating of 'buy' among analysts polled by FactSet. An increased price target can signal confidence in a company's future performance, which often attracts i",
    "url": "https://finnhub.io/api/news?id=43b3439959be51f2c2705ee68f99df557a0c5cb41bf57047240563724ab77ad2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760981742,
      "headline": "Why IQVIA (IQV) Stock Is Trading Up Today",
      "id": 137174760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215. The adjustment from the investment bank suggested a more positive outlook on the stock's potential value. This move occurred while the company maintained an average rating of 'buy' among analysts polled by FactSet. An increased price target can signal confidence in a company's future performance, which often attracts i",
      "url": "https://finnhub.io/api/news?id=43b3439959be51f2c2705ee68f99df557a0c5cb41bf57047240563724ab77ad2"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For October",
    "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
    "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760955567,
      "headline": "IXJ: Healthcare Sector Dashboard For October",
      "id": 137167977,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409850701/image_1409850701.jpg?io=getty-c-w1536",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
      "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826"
    }
  }
]